glp-1 gip and glucagon receptor agonists are increasingly used to treat type 2 diabetes obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal GIP and GLP-1: similarities and

This review highlights the potential clinical benefits of GLP-1 receptor agonists and co-agonists as tools in the management of obesity

PubMed , About the Author: Debbie Moon is a biologist, engineer, author, and the founder of Genetic Lifehacks where she has helped thousands of members understand how to apply genetics to their diet, lifestyle, and health decisions

Greek yogurt and cottage cheese : Soft protein sources that are easier to eat when solid food feels unappealing

Next, I moved on to a 14 mg dose after four or so months, and saw my weight go even more rapidly

The AUC was reduced in the GLP-1RA group as compared to the control group ((F(1,14) = 3.98 p = 0.06, f = 0.55)

Experimental studies indicate that GLP-1 signaling can enhance genioglossus muscle tone, thereby reducing susceptibility to airway collapse during sleep (38, 39)